* Medifast Inc MED.N MED is expected to show a fall in
quarterly revenue when it reports results on November 4 for the
period ending September 30 2024
* The Owings Mills Maryland-based company is expected to
report a
43.1% decrease in revenue to $134.15 million from $235.87
million a year ago, according to the mean estimate from 2
analysts, based on LSEG data.The company's guidance on August 5
2024, for the period ended September 30, was for revenue between
$125.00 million and $145.00 million.
* LSEG's mean analyst estimate for Medifast Inc is for a
loss
of 28 cents per share. The company's EPS guidance on August 5
2024, for the period ended September 30, was between $-0.70 and
$-0.05
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 1
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Medifast
Inc is
17.25, below its last closing price of $18.58.
This summary was machine generated November 2 at 03:50 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)